Study of adverse pregnancy outcome risks following treatment of CMV with ganciclovir or valganciclovir
Researchers with access to the VigiBase database of adverse drug reactions have conducted a disproportionality analysis of adverse pregnancy outcomes to identify safety signals associated with ganciclovir or valganciclovir use in pregnancy. More information can be found here.
The authors of the study have also provided ENTIS with a visual abstract of their study:
Photo by Wengang Zhai on Unsplash